Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 5/20 | 0.45 |
| ▸ | DGAT1 | O75907 | 12/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.33 |
| ▸ | SOAT1 | P35610 | 2/20 | 0.33 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.33 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.32 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14967566 | 0.85 | ERN1 (0.47) | ERN1DGAT1 | |
| SCHEMBL14968031 | 0.84 | ERN1 (0.46) | ERN1DGAT1KCNH2ADORA2A | |
| SCHEMBL14971694 | 0.79 | DGAT1 (0.47) | DGAT1KCNH2SOAT1ADORA2A | |
| SCHEMBL14971629 | 0.78 | DGAT1 (0.48) | DGAT1KCNH2SOAT1ADORA2A | |
| SCHEMBL14967862 | 0.77 | ERN1 (0.39) | ERN1 | |
| SCHEMBL14971611 | 0.76 | DGAT1 (0.44) | DGAT1KCNH2SOAT1ADORA2A | |
| SCHEMBL14971585 | 0.76 | DGAT1 (0.49) | DGAT1KCNH2SOAT1ADORA2A | |
| SCHEMBL14971637 | 0.75 | DGAT1 (0.45) | DGAT1KCNH2SOAT1 | |
| SCHEMBL14971628 | 0.74 | DGAT1 (0.42) | DGAT1KCNH2SOAT1ADORA2A | |
| SCHEMBL14971604 | 0.74 | DHODH (0.49) | DGAT1KCNH2ADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013074387-A1 | IMIDAZOLE DERIVATIVES | MERCK SHARP & DOHME CORP. (US) | 2013-05-23 | — | — | WO | disclosed |
| WO-2013074387-A1 | IMIDAZOLE DERIVATIVES | MERCK SHARP & DOHME CORP. (US) | 2013-05-23 | — | — | WO | disclosed |